{"id":650,"date":"2026-04-24T20:51:02","date_gmt":"2026-04-24T18:51:02","guid":{"rendered":"https:\/\/studienportal-endometriumkrebs.de\/novel-treatment-options-for-the-management-of-advanced-stage-endometrial-cancer\/"},"modified":"2026-07-20T16:51:41","modified_gmt":"2026-07-20T14:51:41","slug":"novel-treatment-options-for-the-management-of-advanced-stage-endometrial-cancer","status":"publish","type":"post","link":"https:\/\/studienportal-endometriumkrebs.de\/en\/novel-treatment-options-for-the-management-of-advanced-stage-endometrial-cancer\/","title":{"rendered":"Novel treatment options for the management of advanced-stage endometrial cancer"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"650\" class=\"elementor elementor-650 elementor-443\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9892029 e-flex e-con-boxed e-con e-parent\" data-id=\"9892029\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b37086d elementor-widget elementor-widget-heading\" data-id=\"b37086d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\"><b>Novel treatment options<\/b> for the management of<br \/> advanced-stage endometrial cancer<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7306ff9 elementor-widget elementor-widget-text-editor\" data-id=\"7306ff9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>In this special presentation from IGCS Advances &#038; Updates, Linda Ryan, a survivor of metastatic recurrent cervical cancer and patient research advocate, shares her story and experiences with clinical trials. Linda is joined by her gynecologic oncologist, Dr. Shannon Westin, Professor of Gynecologic Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas. Listen to Linda and Dr. Westin as they discuss current approval and therapy options for patients with recurrent cervical cancer.<\/p><p><a href=\"https:\/\/igcs.org\/educational-webinars\/\" target=\"_blank\" rel=\"noopener\">Source: https:\/\/igcs.org\/educational-webinars\/<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e859d26 elementor-widget elementor-widget-video\" data-id=\"e859d26\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/www.youtube.com\\\/watch?v=HYBN94EO4Fs&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Novel treatment options for the management of advanced-stage endometrial cancer In this special presentation from IGCS Advances &#038; Updates, Linda Ryan, a survivor of metastatic recurrent cervical cancer and patient research advocate, shares her story and experiences with clinical trials. Linda is joined by her gynecologic oncologist, Dr. Shannon Westin, Professor of Gynecologic Oncology at [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":651,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1,22],"tags":[],"class_list":["post-650","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nicht-kategorisiert","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/studienportal-endometriumkrebs.de\/en\/wp-json\/wp\/v2\/posts\/650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/studienportal-endometriumkrebs.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/studienportal-endometriumkrebs.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/studienportal-endometriumkrebs.de\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/studienportal-endometriumkrebs.de\/en\/wp-json\/wp\/v2\/comments?post=650"}],"version-history":[{"count":1,"href":"https:\/\/studienportal-endometriumkrebs.de\/en\/wp-json\/wp\/v2\/posts\/650\/revisions"}],"predecessor-version":[{"id":652,"href":"https:\/\/studienportal-endometriumkrebs.de\/en\/wp-json\/wp\/v2\/posts\/650\/revisions\/652"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/studienportal-endometriumkrebs.de\/en\/wp-json\/wp\/v2\/media\/651"}],"wp:attachment":[{"href":"https:\/\/studienportal-endometriumkrebs.de\/en\/wp-json\/wp\/v2\/media?parent=650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/studienportal-endometriumkrebs.de\/en\/wp-json\/wp\/v2\/categories?post=650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/studienportal-endometriumkrebs.de\/en\/wp-json\/wp\/v2\/tags?post=650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}